Search research articles
Contact Us
Filters
Showing results (81-90 of 222) with videos related to
Page
of 23
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 2, 2008
Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter study
Lee S Schwartzberg, Edward J Stepanski, Mark S Walker, et al.
Journal of Cancer Survivorship : Research and Practice
|
August 28, 2025
Perceived discrimination, patient-provider communication, and quality of life among breast cancer survivors: a mediation analysis
Freddie Yang, Xin Hu, Janeane N Anderson, et al.
Journal of Medical Economics
|
August 8, 2013
Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer
Paul J E Miller, Sanjeev Balu, Deborah Buchner, et al.
Clinical Lung Cancer
|
November 11, 2009
Second- and third-line treatment of patients with non-small-cell lung cancer with erlotinib in the community setting: retrospective study of patient healthcare utilization and symptom burden
Edward J Stepanski, Arthur C Houts, Lee S Schwartzberg, et al.
Health and Quality of Life Outcomes
|
May 5, 2006
Validation of a patient satisfaction questionnaire for anemia treatment, the PSQ-An
Robert J Nordyke, Chih-Hung Chang, Chiun-Fang Chiou, et al.
Therapeutic Advances in Hematology
|
April 5, 2013
Symptom Burden and Quality of Life in Patients with Follicular Lymphoma undergoing Maintenance Treatment with Rituximab Compared with Observation
Mark S Walker, Edward J Stepanski, Carolina Reyes, et al.
BMC Research Notes
|
June 22, 2012
Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancer
Mark S Walker, Elaine Yu Pharm, Jiandong Kerr, et al.
Breast Cancer Research and Treatment
|
March 6, 2014
Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden
Mark S Walker, Anthony S Masaquel, Jiandong Kerr, et al.
Breast Cancer (Dove Medical Press)
|
December 21, 2016
Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study
Shannon Puhalla, Sharon Wilks, Adam M Brufsky, et al.
Journal of Medical Economics
|
October 10, 2012
Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastases
Mark S Walker, Paul J E Miller, Madhav Namjoshi, et al.
Page
of 23
Search research articles
Search
Showing results (81-90 of 222) with videos related to
Sort By:
Page
of 23
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 2, 2008
Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter study
Lee S Schwartzberg, Edward J Stepanski, Mark S Walker, et al.
Journal of Cancer Survivorship : Research and Practice
|
August 28, 2025
Perceived discrimination, patient-provider communication, and quality of life among breast cancer survivors: a mediation analysis
Freddie Yang, Xin Hu, Janeane N Anderson, et al.
Journal of Medical Economics
|
August 8, 2013
Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer
Paul J E Miller, Sanjeev Balu, Deborah Buchner, et al.
Clinical Lung Cancer
|
November 11, 2009
Second- and third-line treatment of patients with non-small-cell lung cancer with erlotinib in the community setting: retrospective study of patient healthcare utilization and symptom burden
Edward J Stepanski, Arthur C Houts, Lee S Schwartzberg, et al.
Health and Quality of Life Outcomes
|
May 5, 2006
Validation of a patient satisfaction questionnaire for anemia treatment, the PSQ-An
Robert J Nordyke, Chih-Hung Chang, Chiun-Fang Chiou, et al.
Therapeutic Advances in Hematology
|
April 5, 2013
Symptom Burden and Quality of Life in Patients with Follicular Lymphoma undergoing Maintenance Treatment with Rituximab Compared with Observation
Mark S Walker, Edward J Stepanski, Carolina Reyes, et al.
BMC Research Notes
|
June 22, 2012
Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancer
Mark S Walker, Elaine Yu Pharm, Jiandong Kerr, et al.
Breast Cancer Research and Treatment
|
March 6, 2014
Early treatment discontinuation and switching in first-line metastatic breast cancer: the role of patient-reported symptom burden
Mark S Walker, Anthony S Masaquel, Jiandong Kerr, et al.
Breast Cancer (Dove Medical Press)
|
December 21, 2016
Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study
Shannon Puhalla, Sharon Wilks, Adam M Brufsky, et al.
Journal of Medical Economics
|
October 10, 2012
Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastases
Mark S Walker, Paul J E Miller, Madhav Namjoshi, et al.
Page
of 23